Utility‐based Bayesian personalized treatment selection for advanced breast cancer
نویسندگان
چکیده
Journal of the Royal Statistical Society: Series C (Applied Statistics)Volume 71, Issue 5 p. O1-O1 ERRATUMFree Access Utility-based Bayesian personalized treatment selection for advanced breast cancer This article corrects following: Juhee Lee, Peter F. Thall, Bora Lim, Pavlos Msaouel, Volume 71Issue 5Journal Statistics) pages: 1605-1622 First Published online: September 9, 2022 published: 22 December https://doi.org/10.1111/rssc.12606AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text full-text accessPlease review our Terms and Conditions Use check box below share version article.I have read accept Wiley Online Library UseShareable LinkUse link a this with your friends colleagues. Learn more.Copy URL Share linkShare onFacebookTwitterLinkedInRedditWechat The Section 2 heading ‘A BNR MODEL’ should be corrected as BAYESIAN NONPARAMETRIC REGRESSION MODEL’. REFERENCE J., P.F., B. & P. (2022) cancer. Statistics), 71(5), 1605– 1622. Volume71, Issue5November 2022Pages ReferencesRelatedInformation
منابع مشابه
Immunotherapy for Breast Cancer Treatment
Breast cancer, as a heterogeneous disease, includes a wide range of pathological and clinical behaviors. Current treatment protocols, including radiotherapy, chemotherapy, and hormone replacement therapy, are mainly associated with poor response and high rate of recurrence. Therefore, more efforts are needed to develop alternative therapies for this type of cancer. Immunotherapy, as a novel str...
متن کاملPersonalized chemotherapy selection for breast cancer using gene expression profiles
Choosing the optimal chemotherapy regimen is still an unmet medical need for breast cancer patients. In this study, we reanalyzed data from seven independent data sets with totally 1079 breast cancer patients. The patients were treated with three different types of commonly used neoadjuvant chemotherapies: anthracycline alone, anthracycline plus paclitaxel, and anthracycline plus docetaxel. We ...
متن کاملPersonalized Medicine and Imaging Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer
Purpose: Chemotherapy plus trastuzumab is standard of care for HER2-positive advanced gastric cancer (AGC). However, not all patients with HER2-positive AGC seem to benefit from trastuzumab. We evaluated the association between treatment outcomes with trastuzumab and HER2 status in patients with HER2positive AGC. Experimental Design: We enrolled 126 patients with HER2positive AGC treated with t...
متن کاملPersonalized treatment for advanced colorectal cancer: KRAS and beyond
Targeted therapies have improved the survival of patients with advanced colorectal cancer (CRC). However, further improvements in patient outcomes may be gained by the development of predictive biomarkers in order to select individuals who are most likely to benefit from treatment, thus personalizing treatment. Using the epidermal growth-factor receptor (EGFR) pathway, we discuss the existing a...
متن کاملcomparison of higher-order aberrations after personalized treatment versus personalized treatment advanced photorefractive keratectomy for myopia and myopic astigmatism
purpose: the aim of this study was to compare higher-order aberrations between personalized treatment (pt) versus personalized treatment advanced (pta) photorefractive keratectomy (prk) for myopia and myopic astigmatism. methods: in this clinical trial, 80 eyes of 40 patients who met inclusion criteria were enrolled. they underwent prk using pt or pta algorithm randomly. higher-order aberration...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Applied statistics
سال: 2022
ISSN: ['1467-9876', '0035-9254']
DOI: https://doi.org/10.1111/rssc.12606